Presentation is loading. Please wait.

Presentation is loading. Please wait.

Updates in Anticoagulation: What Did We Learn From ESC 2017?

Similar presentations


Presentation on theme: "Updates in Anticoagulation: What Did We Learn From ESC 2017?"— Presentation transcript:

1 Updates in Anticoagulation: What Did We Learn From ESC 2017?

2 COMPASS: Trial Design

3 COMPASS: Pantoprazole-Based Randomization

4 COMPASS: Outcomes

5 COMPASS: Primary Endpoints CV Death, Stroke, MI

6 COMPASS: Primary Components

7 COMPASS: Major Bleeding

8 COMPASS: Net Clinical Benefit

9 COMPASS: Summary

10 RE-DUAL PCI: Study Design Multicenter, Randomized, Open-Label PROBE Trial

11 RE-DUAL PCI: Primary Endpoint ISTH Major or CRNM Bleeding Event

12 RE-DUAL PCI: Rates of TIMI Major or Minor Bleeding

13 RE-DUAL PCI: Summary

14 IMPACT-AF: Cluster Randomized Trial

15 IMPACT-AF: Results Persistence and New Treatment

16 IMPACT AF: Clinical Outcomes

17 EMANATE: Study Design

18 EMANATE: Stroke/SE Outcomes

19 XANTUS: A Worldwide Program

20 XANTUS: Efficacy and Safety in the Real World

21 REHEARSE-AF

22 Abbreviations

23 Abbreviations (cont)


Download ppt "Updates in Anticoagulation: What Did We Learn From ESC 2017?"

Similar presentations


Ads by Google